Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis

Abstract

sNfL indicates acute inflammation as demonstrated by correlation with Gd+ lesions. It is a promising biomarker for neuro-axonal damage in early multiple sclerosis (MS) patients, since higher baseline sNfL levels predicted future brain atrophy within 2 years.